Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago region, 2007 to 2010

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 12, 2013, Pages 6385-6388

  Banerjee, Ritu ^a   Robicsek, Ari ^b   Kuskowski, Michael A ^c   Porter, Stephen ^c   Johnston, Brian D ^c   Sokurenko, Evgeni ^d   Tchesnokova, Veronika ^d   Price, Lance B ^e,f   Johnson, James R ^c  

^a MAYO CLINIC   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AMPICILLIN; CD59 ANTIGEN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; SIDEROPHORE; TOXIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; MOLECULAR EPIDEMIOLOGY; VIRULENCE;

EID: 84887467705     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01604-13     Document Type: Article

References (16)

1. Johnson J, Tchesnokova V, Johnston B, Clabots C, Roberts P, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price L, Aziz M, Nicolas-Chanoine M, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott D, Zhanel G, Weissman S, Cookson B, Fang F, Limaye A, Scholes D, Chattopadhyay S, Hooper D, Sokurenko E. 2013. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J. Infect. Dis. 207:919-928.
2. Price L, Johnson J, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Pearson T, Keim P, Sokurenko E. Epidemic clonal expansion of CTX-M-15-producing Escherichia coli ST131. mBio, in press.
3. Banerjee R, Strahilevitz J, Johnson J, Nagwekar P, Schora D, Shevrin I, Du H, Peterson L, Robicsek A. 2013. Predictors and molecular epidemiology of community-onset extended-spectrum beta-lactamase (ESBL) Escherichia coli infection in a Midwestern community Infect. Control Hosp. Epidemiol. 34:947-953.
4. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66: 4555-4558.
5. Colpan A, Porter S, Johnston B, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson J. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrugresistant pathogen among U.S. veterans. Clin. Infect. Dis. 57:1256-1265.
6. Xu L, Ensor V, Gossain S, Nye K, Hawkey P. 2005. Rapid and simple detection of bla CTX-M genes by multiplex PCR assay. J. Med. Microbiol. 54:1183-1187.
7. CTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob. Agents Chemother. 56:2364-2370.
8. Johnson J, Johnston B, Clabots C, Kuskowski M, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
9. Johnson J, Menard M, Johnston B, Kuskowski M, Nichol K, Zhanel G. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002-2004. Antimicrob. Agents Chemother. 53:2733-2739.
10. Johnson J, Stell A. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272.
11. Johnson J, Murray A, Gajewski A, Sullivan M, Snippes P, Kuskowski M, Smith K. 2003. Isolation and molecular characterization of nalidixic acidresistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob. Agents Chemother. 47:2161-2168.
12. Peakall R, Smouse P. 2006. GENALEX 6: genetic analysis in Excel: population genetic software for teaching and research. Mol. Ecol. Notes 6:288-295.
13. Olesen B, Hansen D, Nilsson F, Frimodt-Møller J, Leihof R, Struve C, Scheutz F, Johnston B, Krogfelt K, Johnson J. 2013. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J. Clin. Microbiol. 51:1779-1785.
14. Pitout JDD, Campbell L, Church DL, Gregson DB, Laupland KB. 2009. Molecular characteristics of travel-related extended-spectrum betalactamase-producing Escherichia coli isolates from the Calgary health region. Antimicrob. Agents Chemother. 53:2539-2543.
15. Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernández V, de la Cruz F, Martínez-Martínez L, Alonso MP, Nicolas-Chanoine M-H, Johnson JR, Johnston B, López-Cerero L, Pascual A, Rodríguez-Baño J, the Spanish Group for Nosocomial Infections (GEIH). 2013. Four main virotypes among extended-spectrum β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J. Clin. Microbiol. 51:3358-3367.
16. Tchesnokova V, Billig M, Chattapadhyay S, Linardopoulou E, Aprikian P, Roberts PL, Skrivankova PV, Johnston B, Gileva A, Igusheva I, Toland A, Riddell K, Rogers P, Qin X, Bulter-Wu S, Cookson BT, Fang FC, Kahl B, Price LB, Weissman SJ, Limaye A, Scholes D, Johnson JR, Sokurenko EV. 2013. Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome. J. Clin. Microbiol. 51:2991-2999.